James Carroll

Loading
James Carroll

James Carroll

CEO, THOR PHOTOMEDICINE LTD
Founder CEO THOR Photomedicine Co-Founder and investor in Lumithera James is a recognised authority on Photobiomodulation (PBM) mechanisms and dose. He co-authored 24 PBM research papers (six with Harvard Medical School) and five books. APPOINTMENTS: Biomedical Optics Society - conference co-chair (2009 - to-date) Fellow of The Royal Society of Medicine (2009 - to-date) Editorial Board of Photomedicine and Laser Surgery (2008 - 2013) World Association for Photobiomodulation Therapy (WALT) board (2000 - 2004 and 2018 - to-date) North American Association for Laser Therapy board member (2002 - 2006)
Sessions

Supported By

  • Adam

  • Physique

  • DJO-Global-Chattanooga

  • Society - low res image 400x400 (002)

  • VENN Healthcare Final

Our Sponsors